Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives

C. E. Curtis, M. E. Calkins, W. M. Grove, K. J. Feil, W. G. Iacono

Research output: Contribution to journalArticle

Abstract

Objective: Performance on measures of saccadic inhibition and control was investigated in a large family study of schizophrenia to evaluate the utility of using antisaccade task performance as an endophenotypic marker of genetic liability for schizophrenia. Method: Ninety-five patients with acute schizophrenia and 116 of their first-degree biological relatives, 13 schizophrenia patients whose illness was in full remission, 35 patients with acute psychotic affective disorder, and 109 nonpsychiatric comparison subjects were administered antisaccade and prosaccade tasks. Results: Both schizophrenia patient groups had a greater number of errors on the antisaccade task than did the first-degree relatives and the affective disorder group, which both had more errors than the comparison subjects. Among the first-degree relatives of the probands with acute schizophrenia, relatives of poor-performing patients performed worse on the antisaccade task than relatives of patients with good performance. Reflexive errors were not likely the result of interfering psychotic symptoms, medication, or medication side effects. Although the schizophrenia patients demonstrated other signs of saccadic abnormalities, these problems, which were not observed in their relatives even though they had high antisaccade error rates, seem unlikely to account for the higher antisaccade error rate of the schizophrenia patients. Conclusions: These findings suggest that saccadic disinhibition is strongly associated with the genetic liability for schizophrenia.

Original languageEnglish (US)
Pages (from-to)100-106
Number of pages7
JournalAmerican Journal of Psychiatry
Volume158
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Schizophrenia
Psychotic Affective Disorders
Task Performance and Analysis
Mood Disorders
Genetic Markers

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives. / Curtis, C. E.; Calkins, M. E.; Grove, W. M.; Feil, K. J.; Iacono, W. G.

In: American Journal of Psychiatry, Vol. 158, No. 1, 2001, p. 100-106.

Research output: Contribution to journalArticle

Curtis, C. E. ; Calkins, M. E. ; Grove, W. M. ; Feil, K. J. ; Iacono, W. G. / Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives. In: American Journal of Psychiatry. 2001 ; Vol. 158, No. 1. pp. 100-106.
@article{7c3fa88cd56c4614afa1f2534141fbed,
title = "Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives",
abstract = "Objective: Performance on measures of saccadic inhibition and control was investigated in a large family study of schizophrenia to evaluate the utility of using antisaccade task performance as an endophenotypic marker of genetic liability for schizophrenia. Method: Ninety-five patients with acute schizophrenia and 116 of their first-degree biological relatives, 13 schizophrenia patients whose illness was in full remission, 35 patients with acute psychotic affective disorder, and 109 nonpsychiatric comparison subjects were administered antisaccade and prosaccade tasks. Results: Both schizophrenia patient groups had a greater number of errors on the antisaccade task than did the first-degree relatives and the affective disorder group, which both had more errors than the comparison subjects. Among the first-degree relatives of the probands with acute schizophrenia, relatives of poor-performing patients performed worse on the antisaccade task than relatives of patients with good performance. Reflexive errors were not likely the result of interfering psychotic symptoms, medication, or medication side effects. Although the schizophrenia patients demonstrated other signs of saccadic abnormalities, these problems, which were not observed in their relatives even though they had high antisaccade error rates, seem unlikely to account for the higher antisaccade error rate of the schizophrenia patients. Conclusions: These findings suggest that saccadic disinhibition is strongly associated with the genetic liability for schizophrenia.",
author = "Curtis, {C. E.} and Calkins, {M. E.} and Grove, {W. M.} and Feil, {K. J.} and Iacono, {W. G.}",
year = "2001",
doi = "10.1176/appi.ajp.158.1.100",
language = "English (US)",
volume = "158",
pages = "100--106",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "1",

}

TY - JOUR

T1 - Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives

AU - Curtis, C. E.

AU - Calkins, M. E.

AU - Grove, W. M.

AU - Feil, K. J.

AU - Iacono, W. G.

PY - 2001

Y1 - 2001

N2 - Objective: Performance on measures of saccadic inhibition and control was investigated in a large family study of schizophrenia to evaluate the utility of using antisaccade task performance as an endophenotypic marker of genetic liability for schizophrenia. Method: Ninety-five patients with acute schizophrenia and 116 of their first-degree biological relatives, 13 schizophrenia patients whose illness was in full remission, 35 patients with acute psychotic affective disorder, and 109 nonpsychiatric comparison subjects were administered antisaccade and prosaccade tasks. Results: Both schizophrenia patient groups had a greater number of errors on the antisaccade task than did the first-degree relatives and the affective disorder group, which both had more errors than the comparison subjects. Among the first-degree relatives of the probands with acute schizophrenia, relatives of poor-performing patients performed worse on the antisaccade task than relatives of patients with good performance. Reflexive errors were not likely the result of interfering psychotic symptoms, medication, or medication side effects. Although the schizophrenia patients demonstrated other signs of saccadic abnormalities, these problems, which were not observed in their relatives even though they had high antisaccade error rates, seem unlikely to account for the higher antisaccade error rate of the schizophrenia patients. Conclusions: These findings suggest that saccadic disinhibition is strongly associated with the genetic liability for schizophrenia.

AB - Objective: Performance on measures of saccadic inhibition and control was investigated in a large family study of schizophrenia to evaluate the utility of using antisaccade task performance as an endophenotypic marker of genetic liability for schizophrenia. Method: Ninety-five patients with acute schizophrenia and 116 of their first-degree biological relatives, 13 schizophrenia patients whose illness was in full remission, 35 patients with acute psychotic affective disorder, and 109 nonpsychiatric comparison subjects were administered antisaccade and prosaccade tasks. Results: Both schizophrenia patient groups had a greater number of errors on the antisaccade task than did the first-degree relatives and the affective disorder group, which both had more errors than the comparison subjects. Among the first-degree relatives of the probands with acute schizophrenia, relatives of poor-performing patients performed worse on the antisaccade task than relatives of patients with good performance. Reflexive errors were not likely the result of interfering psychotic symptoms, medication, or medication side effects. Although the schizophrenia patients demonstrated other signs of saccadic abnormalities, these problems, which were not observed in their relatives even though they had high antisaccade error rates, seem unlikely to account for the higher antisaccade error rate of the schizophrenia patients. Conclusions: These findings suggest that saccadic disinhibition is strongly associated with the genetic liability for schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=0035173312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035173312&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.158.1.100

DO - 10.1176/appi.ajp.158.1.100

M3 - Article

VL - 158

SP - 100

EP - 106

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 1

ER -